http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4037726-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66363368767c45fb4a3ae9ab849a38c6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-0277 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3679 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-342 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3486 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 |
| filingDate | 2020-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04690e760718d8bd4f66ff44db05b761 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c83a8dd0a1f4a53ba3acebca7350451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf6f5aeb348f0c11d6fa85e73c77941d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0658e39e62b786805c2feb73f1fc7186 |
| publicationDate | 2022-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-4037726-A1 |
| titleOfInvention | Assembly for extracorporeal treatment of body fluids |
| abstract | The present invention concerns a method for extracorporeal treatment of a body fluid of a patient suffering from sepsis dysregulated immune response, in an extracorporeal flow line, comprising removing at least one harmful substance from the body fluid of the patient suffering from a dysregulated immune response. The method comprises at least a first injection step, in which, by means of a first injection device, a first mixture containing functionalized magnetic particles bound to at least a first binding agent at least directed against a first type of target molecules contained in the body fluid is added to the extracorporeal flow line comprising a sample of the body fluid extracted from a patient and containing at least the first type of target molecules. The first mixture is injected in a therapeutically effective dose necessary to reduce a concentration of the target molecules of at least the first type in the sample of body fluid of the patient, followed by a mixing step and a separation step for reduction of the target molecule concentration. |
| priorityDate | 2019-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 306.